Home » Topics » BioWorld Science

BioWorld Science
RSS

BTG claims dual AChE/5-HT reuptake inhibitors for AD, depression, etc.

June 9, 2004

Novel quinazolinone-based factor Xa inhibitors developed by BMS scientists

June 9, 2004

Novel DPP-IV inhibitors in early development at BMS

June 9, 2004

GSK researchers prepare and test two series of histamine H3 antagonists or inverse agonists

June 9, 2004

Two series of CGRP antagonists and their use in migraine and other disorders

June 9, 2004

Intranasal insulin improves memory function

June 9, 2004

Recombinant GAD65 shows promise in latent autoimmune diabetes in adults

June 9, 2004

Adenosine receptor antagonist improves insulin sensitivity

June 9, 2004

Investigations of olmesartan reported at ADA congress

June 9, 2004

Antisoma updates recent development efforts

June 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...